Blog
RSS FeedPosted by Michael Wonder on 25 Feb 2022
MAP offers new online pathway for accessing cancer treatments
25 February 2022 - Medicines Australia and Rare Cancers Australia yesterday provided pharmaceutical industry stakeholders a preview of a new ...
Posted by Michael Wonder on 22 Feb 2022
Does the DoH favour some pharmaceutical companies over others?
23 February 2022 - Some interesting insights from version 1 of the agenda for the May 2022 PBAC (intracycle) meeting. ...
Posted by Michael Wonder on 21 Feb 2022
PBS arrangements for medicines for the treatment of paroxysmal nocturnal haemoglobinuria
21 February 2022 - Commencing 1 March 2022, Soliris (eculizumab) and Ultomiris (ravulizumab) will be listed on the Pharmaceutical Benefits Scheme ...
Posted by Michael Wonder on 21 Feb 2022
COVID-19 pandemic sends clear message that Australia must value the long-term health of all Australians
21 February 2022 - Medicines Australia is warning that Australia must act now to ensure that our health system is ...
Posted by Michael Wonder on 20 Feb 2022
New PBS listing to help fight chronic graft versus host disease
20 February 2022 - From 1 March 2022, Australians with chronic graft versus host disease, a complication that can occur when ...
Posted by Michael Wonder on 19 Feb 2022
Breast cancer drug buying time for terminal women amid push for PBS subsidy
20 February 2022 - Alison Day was given just months to live after being diagnosed with stage four terminal breast cancer ...
Posted by Michael Wonder on 15 Feb 2022
‘New hope’: breakthrough cystic fibrosis treatment to be listed on PBS
14 February 2022 - Health Minister Greg Hunt says the breakthrough treatment for cystic fibrosis, Trikafta, will soon be able ...
Posted by Michael Wonder on 14 Feb 2022
Peter paid $60,000 to boost his cancer survival chances, but others miss out
15 February 2022 - Some cancer patients are dipping into their superannuation to pay for treatments under a “two-tiered system” ...
Posted by Michael Wonder on 13 Feb 2022
Novavax – first protein vaccine now available
11 February 2022 - Australia’s first protein vaccine, Novavax will join the national rollout from Monday through select general practices, community ...
Posted by Michael Wonder on 11 Feb 2022
Agenda for the May 2022 PBAC intracycle meeting
11 February 2022 - The agenda for the May 2022 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 10 Feb 2022
National Medicines Policy too important to be rushed before Federal Election
10 February 2022 - Following consultation with members – and heeding the concerns of the Consumers Health Forum and patient ...
Posted by Michael Wonder on 09 Feb 2022
Women in Dobell can’t afford medicine
8 February 2022 - A third of women living in the federal electorate of Dobell struggle to afford prescription medicines, ...
Posted by Michael Wonder on 08 Feb 2022
Pharmacist substitution of PBS medicines without a prescription during shortages (Serious Scarcity Substitution Instrument) - 8 February 2022
8 February 2022 - From 8 February 2022, abatacept syringe (Orencia) and abatacept auto-injector (Orencia ClickJect) can be interchangeably substituted ...
Posted by Michael Wonder on 07 Feb 2022
Review of the National Medicines Policy – consultation on draft National Medicines Policy extended
8 February 2022 - The consultation period on the draft NMP was due to close on Wednesday 16 February 2022. ...
Posted by Michael Wonder on 07 Feb 2022
Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review
7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...